The incidence of lateral pelvic side-wall nodal involvement in low rectal cancer may be similar in Japan and the West

British Journal of Surgery

Volumn 95, Issue 1, 2008, Pages 33-49

  Yano, H ^a,b   Moran, B J ^a  

^a BASINGSTOKE AND NORTH HAMPSHIRE HOSPITAL   (United Kingdom)

^b NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT CHEMOTHERAPY; CANCER STAGING; CANCER SURGERY; COCHRANE LIBRARY; CORRELATION ANALYSIS; DIAGNOSTIC IMAGING; HUMAN; IMAGING SYSTEM; INCIDENCE; JAPAN; LYMPH NODE METASTASIS; LYMPHATIC DRAINAGE; MEDLINE; OUTCOME ASSESSMENT; PELVIS LYMPH NODE; PELVIS LYMPHADENECTOMY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RECTUM CANCER; REVIEW; TREATMENT OUTCOME; EUROPE; LYMPHADENECTOMY; METHODOLOGY; NORTH AMERICA; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PELVIS TUMOR; RECTUM TUMOR;

EUROPE; HUMANS; INCIDENCE; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; NEOPLASM STAGING; NORTH AMERICA; PELVIC NEOPLASMS; RECTAL NEOPLASMS;

EID: 38549119127     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.6061     Document Type: Review

References (105)

1. Heald RJ, Husband EM, Ryall RD. The mesorectum in rectal cancer surgery - the clue to pelvic recurrence? Br J Surg 1982; 69: 613-616.
2. Heald RJ. The 'Holy Plane' of rectal surgery. J R Soc Med 1988; 81: 503-508.
3. MacFarlane JK, Ryall RD, Heald RJ. Mesorectal excision for rectal cancer. Lancet 1993; 341: 457-460.
4. Harling H, Bulow S, Kronborg O, Moller LN, Jorgensen T, Danish Colorectal Cancer Group. Survival of rectal cancer patients in Denmark during 1994-99. Colorectal Dis 2004; 6: 153-157.
5. Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001; 345: 638-646.
6. Martling A, Holm T, Rutqvist LE, Johansson H, Moran BJ, Heald RJ et al. Impact of a surgical training programme on rectal cancer outcomes in Stockholm. Br J Surg 2005; 92: 225-229.
7. Wibe A, Moller B, Norstein J, Carlsen E, Wiig JN, Heald RJ et al. A national strategic change in treatment policy for rectal cancer - implementation of total mesorectal excision as routine treatment in Norway. A national audit. Dis Colon Rectum 2002; 45: 857-866.
8. Twelves C, Wong A, Nowacki MP, Abt M, Burris H III, Carrato A et al. Capecitabine as adjuvant treatment for stage III colon cancer. N Engl J Med 2005; 352: 2696-2704.
9. Krook JE, Moertel CG, Gunderson LL, Wieand HS, Collins RT, Beart RW et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 1991; 324: 709-715.
10. Akasu T, Moriya Y, Ohashi Y, Yoshida S, Shirao K, Kodaira S, for the National Surgical Adjuvant Study of Colorectal Cancer. Adjuvant chemotherapy with uracil-tegafur for pathological stage III rectal cancer after mesorectal excision with selective lateral pelvic lymphadenectomy: a multicenter randomized controlled trial. Jpn J Clin Oncol 2006; 36: 237-244.
11. Cedermark B, Johansson H, Rutqvist LE, Wilking N. The Stockholm I trial of preoperative short term radiotherapy in operable rectal carcinoma. A prospective randomized trial. Stockholm Colorectal Cancer Study Group. Cancer 1995; 75: 2269-2275.
12. Martling A, Holm T, Johansson H, Rutqvist LE, Cedermark B, Stockholm Colorectal Cancer Study Group. The Stockholm II trial on preoperative radiotherapy in rectal carcinoma: long-term follow-up of a population-based study. Cancer 2001; 92: 896-902.
13. Heald RJ, Moran BJ, Ryall RD, Sexton R, MacFarlane JK. Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997. Arch Surg 1998; 133: 894-899.
14. Enker WE, Thaler HT, Cranor ML, Polyak T. Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg 1995; 181: 335-346.
15. Martling AL, Holm T, Rutqvist LE, Moran BJ, Heald RJ, Cedermark B. Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project. Lancet 2000; 356: 93-96.
16. Sebag-Montefiore D, Steele R, Quirke P, Grieve R, Khanna S, Monson J et al. Routine short course pre-op radiotherapy or selective post-op chemoradiotherapy for resectable rectal cancer? Preliminary results of the MRC CR07 randomised trial. J Clin Oncol 2006 24(Suppl): 3511 (Abstract).
17. Adam IJ, Mohamdee MO, Martin IG, Scott N, Finan PJ, Johnston D et al. Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet 1994; 344: 707-711.
18. Quirke P, Durdey P, Dixon MF, Williams NS. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet 1986; 2: 996-999.
19. Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1986; 1: 1479-1482.
20. Bujko K, Nowacki MP, Nasierowska-Guttmejer A, Michalski W, Bebenek M, Kryj M. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 2006; 93: 1215-1223.
21. Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004; 351: 1731-1740.
22. MERCURY Study Group. Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. BMJ 2006; 333: 779.
23. MERCURY Study Group. Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer: results of the MERCURY study. Radiology 2007; 243: 132-139.
24. Koch M, Kienle P, Antolovic D, Buchler MW, Weitz J. Is the lateral lymph node compartment relevant? Recent Results Cancer Res 2005; 165: 40-45.
25. Suzuki K, Muto T, Sawada T. Prevention of local recurrence by extended lymphadenectomy for rectal cancer. Surg Today 1995; 25: 795-801.
26. Heald RJ, Moran BJ. Embryology and anatomy of the rectum. Semin Surg Oncol 1998; 15: 66-71.
27. Heald RJ, Smedh RK, Kald A, Sexton R, Moran BJ. Abdominoperineal excision of the rectum - an endangered operation. Norman Nigro Lectureship. Dis Colon Rectum 1997; 40: 747-751.
28. Radcliffe A. Can the results of anorectal (abdominoperineal) resection be improved: are circumferential resection margins too often positive? Colorectal Dis 2006; 8: 160-167.
29. Gerota D. Die Lymphgefasse des Rectums und des Anus. Arch Anat Physiol 1895; 240.
30. Delamere G, Poirier P, Cuneo B,: The Lymphatics General Anatomy of the Lymphatics. W. T. Keener: Chicago, 1904.
31. Villemin F, Huard P, Montagné M. Recherches anatomiques sur les lymphatiques du rectum et de l'anus: leur applications dans le traitement chirurgical du cancer. Rev Chir 1925; 63: 39-80.
32. Oliveira E. Observacao sobre os linfaticos anoretais. Tese Rio de Janeiro 1947; 77.
33. Sauer I, Bacon HE. Influence of lateral spread of cancer of the rectum on radicability of operation and prognosis. Am J Surg 1951; 81: 111-120.
34. Block I, Enquist I. Lymphatic studies pertaining to local spread of carcinoma of the rectum in the female. Surg Gynecol Obstet 1961; 112: 41-46.
35. Miscusi G, Masoni L, Dell'Anna A, Montori A. Normal lymphatic drainage of the rectum and the anal canal revealed by lymphoscintigraphy. Colo-proctology 1987; 6: 171-174.
36. Sterk P, Keller L, Jochims H, Klein P, Stelzner F, Bruch HP et al. Lymphoscintigraphy in patients with primary rectal cancer: the role of total mesorectal excision for primary rectal cancer - a lymphoscintigraphic study. Int J Colorectal Dis 2002; 17: 137-143.
37. Marr R, Birbeck K, Garvican J, Macklin CP, Tiffin NJ, Parsons WJ et al. The modern abdominoperineal excision: the next challenge after total mesorectal excision. Ann Surg 2005; 242: 74-82.
38. Daniels IR, Fisher SE, Heald RJ, Moran BJ. Accurate staging, selective preoperative therapy and optimal surgery improves outcome in rectal cancer: a review of the recent evidence. Colorectal Dis 2007; 9: 290-301.
39. Nelson H, Petrelli N, Carlin A, Couture J, Fleshman J, Guillem J et al. Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst 2001; 93: 583-596.
40. Wittekind C, Greene FL, Henson DE, Hutter RVP, Sobin LH (eds). TNM Supplement: a Commentary on Uniform Use (3rd edn). International Union Against Cancer. Wiley-Liss: New York, 2003.
41. Salerno G, Sinnatamby C, Branagan G, Daniels IR, Heald RJ, Moran BJ. Defining the rectum: surgically, radiologically and anatomically. Colorectal Dis 2006; 8(Suppl 3): 5-9.
42. Japanese Society for Cancer of the Colon and Rectum. General Rules for Clinical and Pathological Studies on Cancer of the Colon, Rectum and Anus (7th edn). Kanehara: Tokyo, 2006.
43. Goligher JC, Duthie HL, Nixon HH. Surgery of the Anus, Rectum and Colon. Baillière Tindall: London, 1984.
44. Japanese Society for Cancer of the Colon and Rectum. Guidelines for Colon and Rectal Cancer 2005. Kanehara: Tokyo, 2005.
45. Sugihara K, Kobayashi H, Kato T, Mori T, Mochizuki H, Kameoka S et al. Indication and benefit of pelvic sidewall dissection for rectal cancer. Dis Colon Rectum 2006; 49: 1663-1672.
46. Stearns MW Jr, Deddish MR. Five-year results of abdominopelvic lymph node dissection for carcinoma of the rectum. Dis Colon Rectum 1959; 2: 169-172.
47. Glass RE, Ritchie JK, Thompson HR, Mann CV. The results of surgical treatment of cancer of the rectum by radical resection and extended abdomino-iliac lymphadenectomy. Br J Surg 1985; 72: 599-601.
48. Enker WE, Pilipshen SJ, Heilweil ML, Stearns MW Jr, Janov AJ, Hertz RE et al. En bloc pelvic lymphadenectomy and sphincter preservation in the surgical management of rectal cancer. Ann Surg 1986; 203: 426-433.
49. Michelassi F, Block GE, Vannucci L, Montag A, Chappell R. A 5- to 21-year follow-up and analysis of 250 patients with rectal adenocarcinoma. Ann Surg 1988; 208: 379-389.
50. Moriya Y, Hojo K, Sawada T, Koyama Y. Significance of lateral node dissection for advanced rectal carcinoma at or below the peritoneal reflection. Dis Colon Rectum 1989; 32: 307-315.
51. Harnsberger JR, Vernava VM III, Longo WE. Radical abdominopelvic lymphadenectomy: historic perspective and current role in the surgical management of rectal cancer. Dis Colon Rectum 1994; 37: 73-87.
52. Di Matteo G, Mascagni D, Lentini A, Tarroni D, Filippini A. Advances in rectal cancer surgery. Dis Colon Rectum 1994; 37: (Suppl): S50-S53.
53. Moreira LF, Hizuta A, Iwagaki H, Tanaka N, Orita K. Lateral lymph node dissection for rectal carcinoma below the peritoneal reflection. Br J Surg 1994; 81: 293-296.
54. Hida J, Yasutomi M, Fujimoto K, Maruyama T, Okuno K, Shindo K. Does lateral lymph node dissection improve survival in rectal carcinoma? Examination of node metastases by the clearing method. J Am Coll Surg 1997; 184: 475-480.
55. Yamakoshi H, Ike H, Oki S, Hara M, Shimada H. Metastasis of rectal cancer to lymph nodes and tissues around the autonomic nerves spared for urinary and sexual function. Dis Colon Rectum 1997; 40: 1079-1084.
56. Mori T, Takahashi K, Yasuno M. Radical resection with autonomic nerve preservation and lymph node dissection techniques in lower rectal cancer surgery and its results: the impact of lateral lymph node dissection. Langenbecks Arch Sarg 1998; 383: 409-415.
57. Saito N, Koda K, Nobuhiro K, Takiguchi K, Oda K, Soda H et al. Nerve-sparing surgery for advanced rectal cancer patients: special reference to Dukes C patients. World J Surg 1999; 23: 1062-1068.
58. Ueno H, Yamauchi C, Hase K, Ichikura T, Mochizuki H. Clinicopathological study of intrapelvic cancer spread to the iliac area in lower rectal adenocarcinoma by serial sectioning. Br J Surg 1999; 86: 1532-1537.
59. Takahashi T, Ueno M, Azekura K, Ohta H. Lateral node dissection and total mesorectal excision for rectal cancer. Dis Colon Rectum 2000; 43:(Suppl): S59-S68.
60. Nagawa H, Muto T, Sunouchi K, Higuchi Y, Tsurita G, Watanabe T et al. Randomized, controlled trial of lateral node dissection vs. nerve-preserving resection in patients with rectal cancer after preoperative radiotherapy. Dis Colon Rectum 2001; 44: 1274-1280.
61. Fujita S, Yamamoto S, Akasu T, Moriya Y. Lateral pelvic lymph node dissection for advanced lower rectal cancer. Br J Surg 2003; 90: 1580-1585.
62. Morita T, Murata A, Koyama M, Totsuka E, Sasaki M. Current status of autonomic nerve-preserving surgery for mid and lower rectal cancers: Japanese experience with lateral node dissection. Dis Colon Rectum 2003; 46: (Suppl): S78-S88.
63. Matsuoka H, Masaki T, Sugiyama M, Atomi Y. Impact of lateral pelvic lymph node dissection on evacuatory and urinary functions following low anterior resection for advanced rectal carcinoma. Langenbecks Arch Surg 2005; 390: 517-522.
64. Sato H, Maeda K, Maruta M, Masumori K, Koide Y. Who can get the beneficial effect from lateral lymph node dissection for Dukes C rectal carcinoma below the peritoneal reflection? Dis Colon Rectum 2006; 49: (Suppl): S3-S12.
65. Mortenson MM, Khatri VP, Bennett JJ, Petrelli NJ. Total mesorectal excision and pelvic node dissection for rectal cancer: an appraisal. Surg Oncol Clin N Am 2007; 16: 177-197.
66. Miles WE. A method of performing abdomino-perineal excision for carcinoma of the rectum and of the terminal portion of the pelvic colon. Lancet 1908; 2: 1812-1813.
67. Gabriel WB, Dukes C, Bussey HJR. Lymphatic spread in cancer of the rectum. Br J Surg 1935; 23: 395-413.
68. Coller FA, Kay EB, MacIntyre RS. Regional lymphatic metastasis of carcinoma of the rectum. Surgery 1940; 8: 294-311.
69. Grinnell RS. Lymphatic metastases of carcinoma of the colon and rectum. Ann Surg 1950; 131: 494-506.
70. Waugh JM, Kirklin JW. The importance of the level of the lesion in the prognosis and treatment of carcinoma of the rectum and low sigmoid colon. Ann Surg 1949; 129: 22-33.
71. Sauer I, Bacon HE. A new approach for excision of carcinoma of the lower portion of the rectum and anal canal. Surg Gynecol Obstet 1952; 95: 229-242.
72. Senba Y. [An anatomical study of the lymphatic system of the rectum.] J Fukuoka Med Coll 1927; 20: 1213-1268.
73. Kuru M. [Cancer of the rectum.] J Jpn Surg Soc 1940; 41: 832-877.
74. Hojo K, Sawada T, Moriya Y. An analysis of survival and voiding, sexual function after wide iliopelvic lymphadenectomy in patients with carcinoma of the rectum, compared with conventional lymphadenectomy. Dis Colon Rectum 1989; 32: 128-133.
75. Moriya Y, Sugihara K, Akasu T, Fujita S. Nerve-sparing surgery with lateral node dissection for advanced lower rectal cancer. Eur J Cancer 1995; 31A: 1229-1232.
76. Sugihara K, Moriya Y, Akasu T, Fujita S. Pelvic autonomic nerve preservation for patients with rectal carcinoma. Oncologic and functional outcome. Cancer 1996; 78: 1871-1880.
77. Ueno M, Oya M, Azekura K, Yamaguchi T, Muto T. Incidence and prognostic significance of lateral lymph node metastasis in patients with advanced low rectal cancer. Br J Surg 2005; 92: 756-763.
78. Morikawa E, Yasutomi M, Shindou K, Matsuda T, Mori N, Hida J et al. Distribution of metastatic lymph nodes in colorectal cancer by the modified clearing method. Dis Colon Rectum 1994; 37: 219-223.
79. Koda K, Saito N, Oda K, Takiguchi N, Sarashina H, Miyazaki M. Evaluation of lateral lymph node dissection with preoperative chemo-radiotherapy for the treatment of advanced middle to lower rectal cancers. Int J Colorectal Dis 2004; 19: 188-194.
80. Arii K, Takifuji K, Yokoyama S, Matsuda K, Higashiguchi T, Tominaga T et al. Preoperative evaluation of pelvic lateral lymph node of patients with lower rectal cancer: comparison study of MR imaging and CT in 53 patients. Langenbecks Arch Surg 2006; 391: 449-454.
81. Ueno H, Mochizuki H, Hashiguchi Y, Ishiguro M, Miyoshi M, Kajiwara Y et al. Potential prognostic benefit of lateral pelvic node dissection for rectal cancer located below the peritoneal reflection. Ann Surg 2007; 245: 80-87.
82. Hara M, Hirai T, Nakanishi H, Kanemitsu Y, Komori K, Tatematsu M et al. Isolated tumor cell in lateral lymph node has no influences on the prognosis of rectal cancer patients. Int J Colorectal Dis 2007; 22: 911-917.
83. Yano H, Saito Y, Takeshita E, Miyake O, Ishizuka N. Prediction of lateral pelvic node involvement in low rectal cancer by conventional computed tomography. Br J Surg 2007; 94: 1014-1019.
84. Quadros CA, Lopes A, Araujo I, Fahel F, Bacellar MS, Dias CS. Retroperitoneal and lateral pelvic lymphadenectomy mapped by lymphoscintigraphy and blue dye for rectal adenocarcinoma staging: preliminary results. Ann Surg Oncol 2006; 13: 1617-1621.
85. Michelassi F, Block GE. Morbidity and mortality of wide pelvic lymphadenectomy for rectal adenocarcinoma. Dis Colon Rectum 1992; 35: 1143-1147.
86. Enker WE. Potency, cure, and local control in the operative treatment of rectal cancer. Arch Surg 1992; 127: 1396-1402.
87. Maeda K, Maruta M, Utsumi T, Sato H, Toyama K, Matsuoka H. Bladder and male sexual functions after autonomic nerve-sparing TME with or without lateral node dissection for rectal cancer. Tech Coloproctol 2003; 7: 29-33.
88. Kyo K, Sameshima S, Takahashi M, Furugori T, Sawada T. Impact of autonomic nerve preservation and lateral node dissection on male urogenital function after total mesorectal excision for lower rectal cancer. World J Surg 2006; 30: 1014-1019.
89. Matsuoka N, Moriya Y, Akasu T, Fujita S. Long-term outcome of urinary function after extended lymphadenectomy in patients with distal rectal cancer. Eur J Surg Oncol 2001; 27: 165-169.
90. Saito N, Sarashina H, Nunomura M, Koda K, Takiguchi N, Nakajima N. Clinical evaluation of nerve-sparing surgery combined with preoperative radiotherapy in advanced rectal cancer patients. Am J Surg 1998; 175: 277-282.
91. Ueno H, Mochizuki H, Fujimoto H, Hase K, Ichikura T. Autonomic nerve plexus involvement and prognosis in patients with rectal cancer. Br J Surg 2000; 87: 92-96.
92. Matsumoto T, Ohue M, Sekimoto M, Yamamoto H, Ikeda M, Monden M. Feasibility of autonomic nerve-preserving surgery for advanced rectal cancer based on analysis of micrometastases. Br J Surg 2005; 92: 1444-1448.
93. Ueno H, Mochizuki H, Shinto E, Hashiguchi Y, Hase K, Talbot IC. Histologic indices in biopsy specimens for estimating the probability of extended local spread in patients with rectal carcinoma. Cancer 2002; 94: 2882-2891.
94. Roels S, Duthoy W, Haustermans K, Penninckx F, Vandecaveye V, Boterberg T et al. Definition and delineation of the clinical target volume for rectal cancer. Int J Radiat Oncol Biol Phys 2006; 65: 1129-1142.
95. Bipat S, Glas AS, Slors FJ, Zwinderman AH, Bossuyt PM, Stoker J. Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging - a meta-analysis. Radiology 2004; 232: 773-783.
96. Koh DM, Brown G, Temple L, Raja A, Toomey P, Bett N et al. Rectal cancer: mesorectal lymph nodes at MR imaging with USPIO versus histopathologic findings - initial observations. Radiology 2004; 231: 91-99.
97. Moran B, Brown G, Cunningham D, Daniels I, Heald R, Quirke P et al. Clarifying the TNM staging of rectal cancer in the context of modern imaging and neo-adjuvant treatment: 'y' V and 'p' need 'mr' and 'ct'. Colorectal Dis 2007 May 10 (Epub ahead of print).
98. Sobin LH, Wittekind C (eds) International Union Against Cancer: TNM Classification of Malignant Tumours (6th edn). Wiley-Liss: New York, 2002.
99. Grinnell RS. The lymphatic and venous spread of carcinoma of the rectum. Ann Surg 1942; 116: 200-216.
100. Harvey HD, Auchincloss H. Metastases to lymph nodes from carcinomas that were arrested. Cancer 1968; 21: 684-691.
101. Shimoyama M, Yamazaki T, Suda T, Hatakeyama K. Prognostic significance of lateral lymph node micrometastases in lower rectal cancer: an immunohistochemical study with CAM5-2. Dis Colon Rectum 2003; 46: 333-339.
102. Watanabe T, Tsurita G, Muto T, Sawada T, Sunouchi K, Higuchi Y et al. Extended lymphadenectomy and preoperative radiotherapy for lower rectal cancers. Surgery 2002; 132: 27-33.
103. Holm T, Ljung A, Haggmark T, Jurell G, Lagergren J. Extended abdominoperineal resection with gluteus maximus flap reconstruction of the pelvic floor for rectal cancer. Br J Surg 2007; 94: 232-238.
104. Ueno H, Mochizuki H, Hashiguchi Y, Hase K. Prognostic determinants of patients with lateral nodal involvement by rectal cancer. Ann Srg 2001; 234: 190-197.
105. Steup WH, Moriya Y, van de Velde CJ. Patterns of lymphatic spread in rectal cancer. A topographical analysis on lymph node metastases. Eur J Cancer 2002; 38: 911-918.